TERSUS LIFE SCIENCES, LLC
BONITA SPRINGS, FLORIDA

Tersus Life Sciences, LLC is a biopharmaceutical company based in Bonita Springs, Florida. Founded with contributions from Affordable Care Act grants supporting Biomedical Research, Tersus is at the forefront of innovating in the field of cardiovascular health and metabolic syndrome management. They have developed Provinal™, an ultrapurified Omega 7 fatty acid blend known for its potential benefits in addressing issues like Metabolic Syndrome, Insulin resistance, and Diabetes. The company's research and development are led by Dr. Tina Sampalis, M.D., Ph.D., Chief Scientific Officer and a skilled Oncology Surgeon with extensive training in Physiology, Dermatology, Pediatric Surgery, Surgical Research, Epidemiology, and Experimental Surgery. Tersus was joined by other prominent figures such as Dr. Michael Roizen, Chairman of the Wellness Institute at the Cleveland Clinic, who serves on their Scientific Advisory Board. Tersus Life Sciences is recognized for its pioneering efforts in the commercialization of Omega 7 fatty acids, holding multiple patents with many pending, primarily covering novel purification processes that significantly reduce harmful palmitic acid levels. A vital part of their mission includes ensuring a sustainable supply chain for producing Provinal®, leveraging abundant raw materials to meet global demand. With operational and incorporation details anchored in Florida since March 24, 2017, the company's registered office is located at 8000 Health Center Blvd., Bonita Springs, FL. Further contact can be made through their official sites or direct phone lines. The board of directors includes key figures such as OPS Executive Connie Dease, who plays a significant role in steering the strategic direction of Tersus Life Sciences.